Login / Signup

The effectiveness and safety of Kami Guibi-tang for mild cognitive impairment: study protocol of a pilot, randomized, placebo-controlled, double-blind trial.

Hee-Yeon ShinJeong-Hwa KimGeon-Ho JahngWoo-Sang JungSeong-Uk ParkChang-Nam KoJung-Mi Park
Published in: Trials (2019)
Korean Clinical Trial Registry, ID: KCT0002407 . Registered on 30 March 2017.
Keyphrases
  • mild cognitive impairment
  • placebo controlled
  • study protocol
  • double blind
  • clinical trial
  • phase iii
  • phase ii
  • cognitive decline
  • randomized controlled trial
  • open label
  • phase ii study
  • squamous cell carcinoma